XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.3
Share capital (Tables)
9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of assumptions used to estimate the fair value of warrants [Table Text Block]
   

Issue Date

March 10, 2025

   

Issue Date

June 2, 2025

 
Valuation date share price $ 3.40   $ 2.63  
Exercise price $ 2.80   $ 3.10  
Dividend yield   -     -  
Risk-free interest rate   3.98%     4.01%  
Expected warrant life   5.00 years     5.00 years  
Expected volatility   97.81%     97.42%  
Schedule of warrants continuity outstanding and exercisable [Table Text Block]
    Number of
common share
warrants
outstanding
    Number of
common
share
warrants
exercisable
    Weighted
average
exercise
price $
    Weighted
average
remaining
life (years)
 
Outstanding as at  December 31, 2024   1,115,500     1,115,500     0.87     4  
Granted Regulation A Warrants on March 10, 2025   1,490,000     1,490,000     0.70     4  
Granted warrants on June 2, 2025   2,260,000     2,260,000     1.18     5  
Granted Series A and B warrants issued on July 15, 2025   2,680,000     2,680,000     1.69     5  
Exercise of Regulation A warrants   (1,473,800 )   -     2.57     -  
Exercise of public warrants   (129,905 )   -     0.38     -  
Total Warrants outstanding as at September 30, 2025   5,941,795                    
Schedule of warrants outstanding [Table Text Block]
Warrants outstanding  
Expiry date   Exercise price     Number outstanding  
November 15, 2029 $ 4.64     985,595  
March 10, 2030 $ 2.80     16,200  
June 2, 2030 $ 3.10     2,260,000  
July 15, 2030 $ 3.75     2,680,000